UCLA Medical Center Rheumatology

Topics

• Systemic Sclerosis and Related Diseases 428
• Rheumatoid Arthritis Research and Therapies 349
• Systemic Lupus Erythematosus Research 202
• Vasculitis and related conditions 88
• T-cell and B-cell Immunology 66
• Spondyloarthritis Studies and Treatments 61
• Immune Cell Function and Interaction 56
• Monoclonal and Polyclonal Antibodies Research 49
• Gout, Hyperuricemia, Uric Acid 44
• Inflammatory Myopathies and Dermatomyositis 41
• HIV Research and Treatment 40
• Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 25

Most cited

1. The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria.

   Arthritis & rheumatology (Hoboken, N.J.) · 2023 · 404 citations · Sheetal Desai

2. Systemic sclerosis.

   Lancet (London, England) · 2023 · 499 citations · Elizabeth Volkmann

3. 2023 ACR/EULAR antiphospholipid syndrome classification criteria.

   Annals of the rheumatic diseases · 2023 · 343 citations · Sheetal Desai

4. Treatment of Systemic Sclerosis-associated Interstitial Lung Disease: Evidence-based Recommendations. An Official American Thoracic Society Clinical Practice Guideline.

   American journal of respiratory and critical care medicine · 2024 · 150 citations · Elizabeth Volkmann

5. Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours.

   Nature · 2025 · 107 citations · Peter Lloyd

6. Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance.

   Annals of the rheumatic diseases · 2023 · 178 citations · Christina Charles-Schoeman